New Investment to Advance Vialto's Strategic Growth Initiatives and Enable Further Innovation in Technology and Teams Delivering Mobility, Tax, and Immigration Solutions to Clients Transaction ...

WTR is a unique and timely intelligence service informing commercial trademark decision making by assessing the business impact of trademark law developments.

CVC and Clayton, Dubilier & Rice ("CD&R") today confirmed the completion of the previously announced investment in Epicor, a global provider of industry-specific enterprise software to promote ...

Kirkland & Ellis is leading for KKR in its acquisition of a 25 per cent stake in Eni’s biofuel business. The Kirkland team is ...

Sanofi’s chief financial officer, François-Xavier Roger, dismissed concerns about competition with Merck’s shot, saying that Sanofi’s jab has higher efficacy and real world evidence of protection in ...

While online streaming is no doubt convenient and affordable compared with physical media, many of us still prefer owning a physical object like CDs for our music collection. CDs are reliable, they're ...

Streaming and vinyl may be all the rage, but there are plenty of us who have never let go of our CD collection and enjoy listening to and buying CDs to this day. What Hi-Fi? has been testing and ...

“Those bearing the brunt of these new restrictions are small, early-stage companies in the U.S. which not only make up the vast majority — more than 85 percent — of the world’s ...

(RTTNews) - Sanofi (SNYNF) announced it has entered into exclusive negotiations to sell a 50 percent controlling stake in its consumer healthcare business, Opella, to private equity firm CD&R.

The renewed negotiations come after CD&R agreed to pledges around local jobs, investments and production, Bloomberg reported earlier. Sanofi encountered a backlash in France when it chose the US ...

According to Sanofi, the sale of a controlling 50 percent stake in Opella to Clayton Dubilier & Rice (CD&R) has valued the maker of France's leading painkiller, Doliprane, at €16 billion. "Sanofi and ...